HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

METIS TECHBIO-P

17.400

-0.970-5.28%

Volume:10.23M

Turnover:181.10M

Market Cap:20.58B

PE:-31.97

High:19.150

Open:18.300

Low:16.750

Close:18.370

52wk High:29.980

52wk Low:9.460

Shares:1.18B

HK Float Shares:1.08B

Volume Ratio:0.61

T/O Rate:0.94%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.544

ROE:--

ROA:-20.01%

PB:5.84

PE(LYR):-31.97

PS:68.25

Loading ...

Overview Company News Filings

Hong Kong Stock Movers: METIS TECHBIO-P Surges Over 7% Again, Accumulating Nearly 30% Gains Since Early August, Leading AI Drug Discovery Sector for Consecutive Days

AI Drug Developer METIS TECHBIO-P Continues to Attract Market Capital, Shares Surge Over 7% Before Noon

Hong Kong Stocks in Focus: METIS TECHBIO-P (07666) Surges Over 16% in Morning Trade as In-House AiTEM Platform Integrates with Jiangsu Hengrui Pharmaceuticals

Hong Kong Market Movers: Innovative Drug Stocks Rally as Earnings Season Approaches, Medical Conferences Expected to Provide Catalysts

Metis TechBio Appoints Nan Cao as Joint Company Secretary

Metis TechBio Jumps on Jiangsu Hengrui-tie up on AI Formulation Platform

Metis TechBio partners with Hengrui Pharmaceuticals to deploy AiTEM AI formulation platform

Bulletin Express

METIS TECHBIO-P Deploys AI Drug Formulation Platform at HENGRUI PHARMA, Accelerating NanoForge Commercialization

Metis Techbio Co - Announces Aitem AI Platform Deployment at Jiangsu Hengrui Pharmaceuticals

THOMSON REUTERS

METIS TECHBIO-P (07666) Announces CFO Departure and Key Management Changes

Metis Techbio Co - DR. Chong Fu Resigns as CFO, Board Secretary, Joint Company Secretary and Process Agent Effective Aug 1, 2026

THOMSON REUTERS

Metis TechBio CFO Fu Resigns, to Stay on as Adviser

METIS TECHBIO-P Shares Surge Nearly 11% in Session on MTS-128 Global Licensing Deal and "Platform + Product" Growth Strategy

AI-Powered Drug Development Accelerates Commercialization with Major Partnerships and Industry Giants Entering the Field (Related Stocks Listed)

METIS TECHBIO-P Shares Surge Over 5% on Landmark MTS-128 Licensing Deal

Metis TechBio Reports 2.9% Expansion in H-Share Base Following Full Exercise of Over-Allotment Option

Bulletin Express

METIS TECHBIO-P Surges Over 6% in Early Trading Following $1.6 Billion Preclinical TCE Licensing Deal

Metis Techbio and Boulevard Bio Enter Global License Agreement for Trispecific T-cell Engager

THOMSON REUTERS

Hk-listed Metis Techbio Climbs on Boulevard Bio Tie-up

Metis Techbio Signs Global Licensing Deal for Biologic Drug Worth up to $1.6 Billion

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/07666/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"07666","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07666\",,,,,undefined,":{"symbol":"07666","market":"HK","secType":"STK","nameCN":"METIS TECHBIO-P","latestPrice":17.4,"timestamp":1789027722340,"preClose":18.37,"halted":0,"volume":10231700,"delay":0,"changeRate":-0.05280348394120862,"floatShares":1083000000,"shares":1183000000,"eps":-0.544206290719192,"marketStatus":"Closed","change":-0.97,"latestTime":"09-10 16:08:42","open":18.3,"high":19.15,"low":16.75,"amount":181095653,"amplitude":0.130648,"askPrice":17.4,"askSize":6000,"bidPrice":17.38,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":-0.40192315654110333,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":18.37,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0.613402,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07666\",,,,,undefined,":{"symbol":"07666","floatShares":1083000000,"roa":"-20.01%","roe":"--","lyrEps":-0.544206,"volumeRatio":0.613402,"shares":1183000000,"dividePrice":0,"high":19.15,"amplitude":0.130648,"preClose":18.37,"low":16.75,"week52Low":9.46,"pbRate":"5.84","psRate":"68.25","week52High":29.98,"institutionHeld":0,"latestPrice":17.4,"committee":-0.5,"eps":-0.544206290719192,"divideRate":0,"volume":10231700,"delay":0,"ttmEps":-0.40192315654110333,"open":18.3,"prevYearClose":10.5,"prevWeekClose":13.82,"prevMonthClose":12.9,"prevQuarterClose":15.36,"fiveDayClose":13.16,"twentyDayClose":13.19,"sixtyDayClose":14.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/07666\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"07666","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"07666\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"07666\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1783526400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/07666\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"07666","date":"2026-09-09","current":-43.25446,"percent":0.04878,"low":-64.32629,"twenty":-39.427366,"median":-35.143814,"eighty":-28.808744,"high":-25.115126,"avg":-35.864862,"sd":7.955421,"marketCap":21726159504},"quantilePoints":[{"date":"2026-05-15","current":-55.2918,"twenty":-62.155958,"median":-58.000435,"eighty":-43.892829,"marketCap":25009550545},{"date":"2026-05-22","current":-43.108917,"twenty":-60.122045,"median":-51.319082,"eighty":-42.587932,"marketCap":19454433788},{"date":"2026-05-29","current":-37.615042,"twenty":-57.955137,"median":-43.960548,"eighty":-41.311685,"marketCap":17034154703},{"date":"2026-06-05","current":-35.730788,"twenty":-53.702713,"median":-41.754744,"eighty":-37.805412,"marketCap":16204344731},{"date":"2026-06-12","current":-33.542538,"twenty":-49.179944,"median":-39.902739,"eighty":-33.466041,"marketCap":15201657681},{"date":"2026-06-18","current":-36.557324,"twenty":-45.569099,"median":-38.090968,"eighty":-33.980188,"marketCap":16607724578},{"date":"2026-06-26","current":-33.269555,"twenty":-43.790222,"median":-37.525599,"eighty":-33.862793,"marketCap":15040305742},{"date":"2026-07-03","current":-35.486471,"twenty":-43.108917,"median":-37.328817,"eighty":-34.391053,"marketCap":16054517930},{"date":"2026-07-10","current":-31.831683,"twenty":-41.806456,"median":-36.56437,"eighty":-33.415043,"marketCap":14383372848},{"date":"2026-07-17","current":-25.695281,"twenty":-41.703031,"median":-36.419402,"eighty":-32.652478,"marketCap":11651915023},{"date":"2026-07-24","current":-28.586248,"twenty":-41.050787,"median":-35.730788,"eighty":-30.94587,"marketCap":12965780812},{"date":"2026-07-31","current":-26.182193,"twenty":-40.132349,"median":-35.165287,"eighty":-28.502242,"marketCap":11897940371},{"date":"2026-08-07","current":-28.884867,"twenty":-39.287405,"median":-34.015343,"eighty":-27.992619,"marketCap":13151600092},{"date":"2026-08-14","current":-31.416679,"twenty":-38.648807,"median":-33.542538,"eighty":-28.093751,"marketCap":14322470963},{"date":"2026-08-21","current":-36.861025,"twenty":-38.587758,"median":-33.478791,"eighty":-28.154822,"marketCap":16841617384},{"date":"2026-08-28","current":-39.81123,"twenty":-38.587758,"median":-34.218497,"eighty":-28.502242,"marketCap":16415846158},{"date":"2026-09-04","current":-39.623229,"twenty":-38.587758,"median":-34.599368,"eighty":-28.723646,"marketCap":16344884287},{"date":"2026-09-09","current":-52.584342,"twenty":-39.427366,"median":-35.143814,"eighty":-28.808744,"marketCap":21726159504}],"updateTime":1789028090846},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"07666\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1160528287","title":"Hong Kong Stock Movers: METIS TECHBIO-P Surges Over 7% Again, Accumulating Nearly 30% Gains Since Early August, Leading AI Drug Discovery Sector for Consecutive Days","url":"https://stock-news.laohu8.com/highlight/detail?id=1160528287","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160528287?lang=en_us&edition=fundamental","pubTime":"2026-08-11 13:00","pubTimestamp":1786424422,"startTime":"0","endTime":"0","summary":"METIS TECHBIO-P (07666) has seen continued capital inflows, leading the AI drug discovery sector for multiple consecutive days, with cumulative gains of nearly 30% since the beginning of August. As...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTOC","07666","ARTY","BK4588","AGIX","AIPO","KCAI","VTHR","BK4585","BK1191","BK1161","BK1574","CHAT","01477","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119342657","title":"AI Drug Developer METIS TECHBIO-P Continues to Attract Market Capital, Shares Surge Over 7% Before Noon","url":"https://stock-news.laohu8.com/highlight/detail?id=1119342657","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119342657?lang=en_us&edition=fundamental","pubTime":"2026-08-10 11:42","pubTimestamp":1786333320,"startTime":"0","endTime":"0","summary":"Hot sector self-selected stocks, data centers, market trends, capital flows, and simulated trading clients are all focusing on METIS TECHBIO-P (07666). The stock continues to attract market capital,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127214106","title":"Hong Kong Stocks in Focus: METIS TECHBIO-P (07666) Surges Over 16% in Morning Trade as In-House AiTEM Platform Integrates with Jiangsu Hengrui Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=1127214106","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127214106?lang=en_us&edition=fundamental","pubTime":"2026-08-10 09:38","pubTimestamp":1786325900,"startTime":"0","endTime":"0","summary":"METIS TECHBIO-P (07666) shares climbed more than 16% during early trading on the Hong Kong Stock Exchange, last changing hands at HK$12.87, representing a 15.74% gain with turnover reaching...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09834","LU2097828474.EUR","01276","LU1655091616.SGD","CWC","KOMP","TECY","03086","BK0060","BK0183","KCAI","NJAN","QQQX","LU2543165471.USD","NBDS","VXUS","CHAT","PSQ","LU0405327494.USD","03034","07666","QLD","FWD","LU1064130708.USD","PBOT","02834","AIBU","NOCT","LU1255011170.USD","DQJN","LU1146622755.USD","BK0196","QMAR","AQGX","BK4585","LU2328871848.SGD","VUSE","07261","LU1328615791.USD","LU1997245094.SGD","LU2097828714.EUR","LU2488822045.USD","BK1191","600276","AGIX","LU2097828631.EUR","TQQQ","LU0405327148.USD","QQQM","QTOC","OGIG","BK0188","LU2495084118.USD","TARK","LU1781817850.SGD","TQQY","03455","LU1997245177.USD","LU1820825898.SGD","MFIG","QID","LU1580142542.USD","CPNQ","09086","BK0012","GPIQ","161631","LU2148510915.USD","NEWZ","07522","QDEC","ARTY","AIFD","GK","QQA","NJUL","BK0239","07568","LU1023057109.AUD","LU2097828557.USD","LU0359202008.SGD","LCLG","NAPR","QSWN","LU2289578879.USD","07266","WPAI","LU2580892789.USD","BK4588","BK4593","SQQQ","BK1161","LU1969619763.USD","BK0028","LU0359201885.HKD","LU0359201612.USD","AIQU","LU1064131003.USD","LU2580892862.HKD","LU1997244956.HKD","QQQ","MVPS","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181390081","title":"Hong Kong Market Movers: Innovative Drug Stocks Rally as Earnings Season Approaches, Medical Conferences Expected to Provide Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1181390081","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181390081?lang=en_us&edition=fundamental","pubTime":"2026-08-07 11:36","pubTimestamp":1786073814,"startTime":"0","endTime":"0","summary":"Innovative drug stocks are broadly trending higher, with ZAI LAB (09688) surging 14.32% to HK$16.61, WUXI XDC (02268) climbing 9.48% to HK$60.65, and WUXI BIO (02269) advancing 6.19% to HK$43.94....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU0823426308.USD","SG9999002562.SGD","LU2039709279.SGD","BK4588","LU0052750758.USD","LU0516423091.SGD","BK1576","LU0039217434.USD","07666","BK1141","BK1589","LU0856984785.SGD","LU0307460666.USD","LU0819121731.USD","MEDX","02269","BK1161","LU0348825331.USD","LNGR","LU0359202008.SGD","BK4585","LU0516423174.USD","LU1242518857.USD","LU2488822045.USD","LU3063872942.SGD","LU1688375341.USD","LU0043850808.USD","06978","KCAI","LU0823426480.USD","LU0140636845.USD","LU0456827905.SGD","LU0516422366.SGD","LU1794554557.SGD","09688","BK1515","BK1574","02268","LU0051755006.USD","LU0417516738.SGD","LU0327786744.USD","SG9999014674.SGD","IBBQ","BK1521","LU0588546209.SGD","IE00B0JY6N72.USD","LU0708995583.HKD","LU0320764599.SGD","LU0359201612.USD","LU0456846285.SGD","LU0979878070.USD","BK1610","KURE","LU1242518931.SGD","LU0181495838.USD","LU1880383366.USD","LU0516422952.EUR","LU0516422440.USD","LU0348735423.USD","LU0572944931.SGD","LU1720050803.USD","SG9999002463.SGD","159992","VXUS","01672","LU0417516902.SGD","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656591035","title":"Metis TechBio Appoints Nan Cao as Joint Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2656591035","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656591035?lang=en_us&edition=fundamental","pubTime":"2026-08-04 21:04","pubTimestamp":1785848678,"startTime":"0","endTime":"0","summary":"Metis TechBio appoints Nan Cao as joint company secretaryMetis TechBio appointed Nan Cao as joint company secretary effective Aug. 4, 2026.Cao joined the company in 2023 as legal manager; previously w","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL3v797q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656289563","title":"Metis TechBio Jumps on Jiangsu Hengrui-tie up on AI Formulation Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2656289563","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656289563?lang=en_us&edition=fundamental","pubTime":"2026-08-03 13:48","pubTimestamp":1785736133,"startTime":"0","endTime":"0","summary":"BUZZ-Metis TechBio jumps on Jiangsu Hengrui-tie up on AI formulation platform** Shares of Metis TechBio7666.HKjump 9.3% in the second rising session to HK$11, their highest level since July 28** Stock","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N44004N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997244956.HKD","BK1191","BK0183","LU2580892789.USD","LU1969619763.USD","01276","LU1255011170.USD","BK0060","LU1655091616.SGD","BK1161","LU2495084118.USD","BK0196","LU2097828474.EUR","LU1328615791.USD","LU1064130708.USD","LU0359201612.USD","LU1997245094.SGD","LU2328871848.SGD","LU1023057109.AUD","LU2097828805.USD","LU1146622755.USD","LU0405327494.USD","LU2289578879.USD","600276","LU2543165471.USD","BK0188","LU1580142542.USD","07666","LU0359202008.SGD","LU2488822045.USD","BK0028","BK0012","LU1820825898.SGD","LU0359201885.HKD","LU2580892862.HKD","BK0239","LU1781817850.SGD","LU2148510915.USD","LU0405327148.USD","LU2097828631.EUR","LU2097828714.EUR","LU1997245177.USD","LU1064131003.USD","LU2097828557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153759405","title":"Metis TechBio partners with Hengrui Pharmaceuticals to deploy AiTEM AI formulation platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1153759405","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153759405?lang=en_us&edition=fundamental","pubTime":"2026-08-03 12:25","pubTimestamp":1785731100,"startTime":"0","endTime":"0","summary":"Metis TechBio announced that its proprietary AiTEM artificial-intelligence formulation innovation platform will be locally installed at Jiangsu Hengrui Pharmaceuticals. The cooperation aims to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103059933","title":"METIS TECHBIO-P Deploys AI Drug Formulation Platform at HENGRUI PHARMA, Accelerating NanoForge Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=1103059933","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103059933?lang=en_us&edition=fundamental","pubTime":"2026-08-03 12:20","pubTimestamp":1785730837,"startTime":"0","endTime":"0","summary":"On August 3, METIS TECHBIO-P (07666) announced that its self-developed AiTEM AI drug formulation innovation platform will be locally deployed at HENGRUI PHARMA (600276.SH, 01276) to enhance drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","CHAT","LU0359201612.USD","LU2097828631.EUR","LU1023057109.AUD","BK1191","LU2097828557.USD","01276","BK0060","BK0183","BK0188","LU1997245177.USD","VTHR","BK0196","LU0359202008.SGD","BK0028","LU2289578879.USD","LU2495084118.USD","LU2097828714.EUR","LU1781817850.SGD","BK0012","LU1997245094.SGD","LU2097828805.USD","AIPO","LU1655091616.SGD","LU1146622755.USD","LU1969619763.USD","LU1064130708.USD","LU0405327494.USD","AGIX","LU1820825898.SGD","LU2148510915.USD","07666","LU1580142542.USD","QTOC","LU2097828474.EUR","BK1161","LU1064131003.USD","LU1997244956.HKD","LU2328871848.SGD","LU0405327148.USD","LU1328615791.USD","LU2580892789.USD","600276","LU2488822045.USD","BK0239","LU2580892862.HKD","LU1255011170.USD","ARTY","LU0359201885.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656347187","title":"Metis Techbio Co - Announces Aitem AI Platform Deployment at Jiangsu Hengrui Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2656347187","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656347187?lang=en_us&edition=fundamental","pubTime":"2026-08-03 12:06","pubTimestamp":1785729994,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN43Y00Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["600276","LU1969619763.USD","LU1781817850.SGD","LU2148510915.USD","LU1997244956.HKD","BK0028","LU2097828631.EUR","LU2488822045.USD","BK0060","LU1064130708.USD","BK0183","LU2097828557.USD","LU1580142542.USD","LU2097828805.USD","LU2289578879.USD","LU2580892789.USD","LU2328871848.SGD","LU1064131003.USD","BK0188","LU0405327494.USD","LU2097828714.EUR","LU0405327148.USD","LU2097828474.EUR","LU1997245094.SGD","BK0196","07666","BK0239","LU1997245177.USD","LU2495084118.USD","LU1255011170.USD","BK1161","LU1655091616.SGD","LU1146622755.USD","LU2580892862.HKD","BK0012","LU1328615791.USD","LU1820825898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186848474","title":"METIS TECHBIO-P (07666) Announces CFO Departure and Key Management Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=1186848474","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186848474?lang=en_us&edition=fundamental","pubTime":"2026-07-31 21:16","pubTimestamp":1785503778,"startTime":"0","endTime":"0","summary":"METIS TECHBIO-P (07666) has announced that Dr. Fu Chong has resigned from his positions as Chief Financial Officer, Board Secretary, Joint Company Secretary, and Authorized Representative due to work...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655023369","title":"Metis Techbio Co - DR. Chong Fu Resigns as CFO, Board Secretary, Joint Company Secretary and Process Agent Effective Aug 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655023369","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655023369?lang=en_us&edition=fundamental","pubTime":"2026-07-31 21:09","pubTimestamp":1785503362,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X29D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655690793","title":"Metis TechBio CFO Fu Resigns, to Stay on as Adviser","url":"https://stock-news.laohu8.com/highlight/detail?id=2655690793","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655690793?lang=en_us&edition=fundamental","pubTime":"2026-07-31 21:09","pubTimestamp":1785503360,"startTime":"0","endTime":"0","summary":"Metis TechBio CFO Fu resigns, to stay on as adviserMetis TechBio: CFO, board secretary, joint company secretary Chong Fu resigns effective Aug. 1, 2026; shifts to adviser on capital, international dev","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL6X31BG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180427760","title":"METIS TECHBIO-P Shares Surge Nearly 11% in Session on MTS-128 Global Licensing Deal and \"Platform + Product\" Growth Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1180427760","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180427760?lang=en_us&edition=fundamental","pubTime":"2026-07-21 13:47","pubTimestamp":1784612857,"startTime":"0","endTime":"0","summary":"Shares of METIS TECHBIO-P (ASX: 07666) surged nearly 11% during the trading session. At the time of writing, the stock was up 6.2% to HK$11.3, with a turnover of HK$20.19 million. Key Catalyst: Major...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","KCAI","07666","VXUS","BK1161","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101295915","title":"AI-Powered Drug Development Accelerates Commercialization with Major Partnerships and Industry Giants Entering the Field (Related Stocks Listed)","url":"https://stock-news.laohu8.com/highlight/detail?id=1101295915","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101295915?lang=en_us&edition=fundamental","pubTime":"2026-07-16 07:19","pubTimestamp":1784157551,"startTime":"0","endTime":"0","summary":"The pace of commercialization for AI-driven drug discovery is accelerating. Insilico (03696) recently announced that the first candidate drug powered by its proprietary generative AI platform has...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","AGIX","01477","BK4585","CHAT","07666","BK4588","KCAI","BK1161","QTOC","03696","VTHR","BK1574","BK1141","ARTY","BK1191","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159297282","title":"METIS TECHBIO-P Shares Surge Over 5% on Landmark MTS-128 Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1159297282","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159297282?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:30","pubTimestamp":1784082627,"startTime":"0","endTime":"0","summary":"Shares of METIS TECHBIO-P (ASX: 07666) have surged more than 5%. At the time of writing, the stock is up 5.49% to HK$11.15, with a trading turnover of HK$3.1599 million. The catalyst for the move is...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4588","07666","BK4585","VXUS","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187059359","title":"Metis TechBio Reports 2.9% Expansion in H-Share Base Following Full Exercise of Over-Allotment Option","url":"https://stock-news.laohu8.com/highlight/detail?id=1187059359","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187059359?lang=en_us&edition=fundamental","pubTime":"2026-07-06 16:59","pubTimestamp":1783328380,"startTime":"0","endTime":"0","summary":"Metis TechBio Co., Ltd. (METIS TECHBIO-P) disclosed its Monthly Return for Equity Issuer for June 2026, highlighting a notable enlargement of its Hong Kong–listed H-share capital driven by the full...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155258968","title":"METIS TECHBIO-P Surges Over 6% in Early Trading Following $1.6 Billion Preclinical TCE Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1155258968","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155258968?lang=en_us&edition=fundamental","pubTime":"2026-07-03 11:22","pubTimestamp":1783048969,"startTime":"0","endTime":"0","summary":"Shares of METIS TECHBIO-P (ASX: 07666) climbed more than 6% during the morning session.At the time of writing, the stock was up 5.85% to HK$14.29, with a turnover of HK$5.8649 million. Major...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647531620","title":"Metis Techbio and Boulevard Bio Enter Global License Agreement for Trispecific T-cell Engager","url":"https://stock-news.laohu8.com/highlight/detail?id=2647531620","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647531620?lang=en_us&edition=fundamental","pubTime":"2026-06-30 17:37","pubTimestamp":1782812255,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nTUACF9BVZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647580197","title":"Hk-listed Metis Techbio Climbs on Boulevard Bio Tie-up","url":"https://stock-news.laohu8.com/highlight/detail?id=2647580197","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647580197?lang=en_us&edition=fundamental","pubTime":"2026-06-30 14:58","pubTimestamp":1782802687,"startTime":"0","endTime":"0","summary":"BUZZ-HK-listed Metis TechBio climbs on Boulevard Bio tie-up** Metis TechBio7666.HKclimbs 4.7% to HK$15.28** The firm, which develops AI-driven nanomaterial platform technologies, said it entered into ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nL1N432065:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647584371","title":"Metis Techbio Signs Global Licensing Deal for Biologic Drug Worth up to $1.6 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2647584371","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647584371?lang=en_us&edition=fundamental","pubTime":"2026-06-30 12:26","pubTimestamp":1782793566,"startTime":"0","endTime":"0","summary":"Metis TechBio signs global licensing deal for biologic drug worth up to $1.6 billionJune 30 -Hong Kong-listed Metis TechBio said on Tuesday it has granted U.S.-based biotechnology firm Boulevard Bio exclusive global rights to develop, manufacture and commercialise its experimental biologic drug MTS-128 in a deal that could be worth up to $1.6 billion.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nL4N4320B4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":111,"code":"91000000","status":"200"}]}}